Tempest Therapeutics, Inc. (TPST)

NASDAQ: TPST · IEX Real-Time Price · USD

3.100

-0.070 (-2.21%)

At close: Apr 19, 2024, 4:00 PM

3.150

+0.050 (1.61%)

After-hours: Apr 19, 2024, 7:51 PM EDT

Tempest Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-29.49	-35.71	-28.3	-19.21	-44.57	-27.19	-84.58	-82.26	-73.22	-49.52	Upgrade
Depreciation & Amortization	2.08	1.81	1.27	0.82	1.05	0.03	0.03	2.24	1.29	0.45	Upgrade
Share-Based Compensation	2.55	1.56	1.11	0.45	4.32	1.43	0.76	9.37	19.5	12.41	Upgrade
Other Operating Activities	-2.49	1.26	-0.03	-1.08	-2.02	2.09	63.45	8.92	2.15	6.08	Upgrade
Operating Cash Flow	-27.36	-31.07	-25.96	-19.02	-41.22	-23.65	-20.34	-61.73	-50.29	-30.59	Upgrade
Capital Expenditures	-0.17	-0.56	-0.14	-0.05	-0.4	-0.04	-0	-2.59	-5.23	-2.8	Upgrade
Acquisitions	0	0	0	0	0	-0.52	0.46	-1.75	-1.5	-1.5	Upgrade
Change in Investments	0	0	0.04	0.04	4.39	2.49	0	12.43	-30.88	-28.38	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	0.2	-0.68	-0.11	Upgrade
Investing Cash Flow	-0.17	-0.56	-0.1	-0.01	3.99	1.93	0.46	8.29	-38.29	-32.79	Upgrade
Share Issuance / Repurchase	35.6	16.14	44.16	0.07	27.15	38.76	0	54.15	125.39	51.71	Upgrade
Debt Issued / Paid	0	-4.74	15	0	-0.2	6.48	-4.47	0	0	0	Upgrade
Other Financing Activities	-	-	-0.1	34.53	-	32.51	-	-	-	-	Upgrade
Financing Cash Flow	35.6	11.4	59.06	34.6	26.94	77.74	-4.46	54.15	125.39	51.71	Upgrade
Exchange Rate Effect	0	0	0	0	0.03	0.12	0.02	0	0	0	Upgrade
Net Cash Flow	8.08	-20.23	33.01	15.58	-10.26	56.15	-24.33	0.71	36.81	-11.66	Upgrade
Free Cash Flow	-27.53	-31.63	-26.09	-19.07	-41.62	-23.68	-20.34	-64.32	-55.52	-33.39	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-	-9849.92%	-20041.52%	-	Upgrade
Free Cash Flow Per Share	-1.79	-2.74	-6.88	-40.73	-45.55	-229.63	-128.31	-450.17	-461.17	-331.75	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).